Synexus (United Kingdom)

Recent papers from Synexus (United Kingdom)

1. The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insightEpidemiology and Infection · 2024
2. A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic countryVaccine · 2023
3. Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled TrialENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2022
4. Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)Human Vaccines & Immunotherapeutics · 2021
5. The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70Clinical Infectious Diseases · 2021
6. Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant2021
7. Rheumatoid arthritis : a joint ventureSouth African General Practitioner · 2020
8. Dexmedetomidine-based monitored conscious sedation combined local anesthesia for levator resection in a 10-year-old child with Marcus Gunn jaw-winking synkinesisMedicine · 2017
9. Return of the lysergamides. Part II: Analytical and behavioural characterization of N⁶‐allyl‐6‐norlysergic acid diethylamide (AL‐LAD) and (2’S,4’S)‐lysergic acid 2,4‐dimethylazetidide (LSZ)Drug Testing and Analysis · 2016
10. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐d‐lysergic acid diethylamide (1P‐LSD)Drug Testing and Analysis · 2015
11. Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with PsoriasisActa Dermato Venereologica · 2015
12. Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation‐predominant irritable bowel syndromeAlimentary Pharmacology & Therapeutics · 2006